1[1]Chisari Fy&Ferrari C. Hepatitis B virus immunopathology [J].Springer Semin Immunopathol, 1995,17: 261.
2[2]Ando K,Guidotti LG,Wirth S, et al. Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo[J].J Immunol, 1994,152: 3245.
3[3]Ando K, Moriyama T, Guidotti LG, et al. Mechanisms of class-I restricted immunopathology [J]. J Exp Med, 1993,178:1541.
5[5]Guidotti LG, Ando K, Hobbs MV, et al. Cytotoxic T lymphocyte inhibits Bvirus gene expression by a noncytolytic mechanisim in transgenic mice[ J ]. PNAS USA, 1993,91:3764.
6[6]Guidotte LG,Guilhot S, Chisari FV, Interlukin-2 and interferon-al-pha/beta downregulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and I-independent pathways[J]. J Virol, 1994,68:1265.
7[7]Guilhot S, Guidotte LG, Chisari FV. Interlukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a post-transcriptional mechanism[J ]. J Virol, 1993,67: 7444.
8[8]Guidotti LG, Borrow P, Hobbs MV, et al. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver[J ]. PNAS USA, 1996,94: 4589.
9[9]Cavanaugh V J, Guidotti LG, Chisari FV, et al. Inhibition of heaptitis B virus replication during adenovirus and cytomegalovirus infection in transgenic mice[J ]. J. Virol, 1998,72: 2630.
10[10]Guidotti LG, Rochford R, Chung J, et al. Viral clearance without destruction of infected cells during acute HBV infection [ J ]. Science, 1999,284: 825.
同被引文献14
1Webster GJ, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology, 2000, 32(5): 1117-1124.
2Trippler M, Meyer zum Buschenfelde KH, Gerken G. HBV viral load within subpopulations of peripheral blood mononuclear cells in HBV infection using limiting dilution PCR. J Virol Methods. 1999, 78 ( 1-2 ) :129-147.
3Knoller DA, Gerken G. Local control of the immune response in the liver, Immunol Rev, 2000, 174: 21-34.
4Thimme R, Pemberton J, Chisari FV, et al. Analysis of a successful immune response against HBV. Hepatology, 2000, 32: 392A.
5Penna A, Del Prete G, Cavalli A, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology, 1997, 25(4): 1022-1027.
6Cavanaugh V J, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B vires replication in transgenic mice. J Virol, 1997, 71(4): 3236-3243.
7Webster GJM, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology, 2000, 32(5): 1117-1124.
8Doherty DG, O' Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev, 2000, 174: 5-20.
9Rehermann B, Ferrari C, Pasquinelli C, et al. The hepatitis B virus persists for decades after patient's recovery from acute viral hepatitis despite active maintenance of cytotoxic T-lymphocyte response. Nat Med,1996, 2(10) : 1104-1108.
10Nakamoto Y, Guidotti LG, Pasquetto V, et al. Differiential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J Immunol, 1997, 158(12): 5692-5697.
